Cambridge Investment Research Advisors, Inc. Mimedx Group, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.6 Billion
- Q1 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 12,630 shares of MDXG stock, worth $85,757. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,630
Previous 13,130
3.81%
Holding current value
$85,757
Previous $126,000
23.81%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding MDXG
# of Institutions
240Shares Held
102MCall Options Held
128KPut Options Held
116K-
Essex Woodlands Management, Inc. The Woodlands, TX28.2MShares$191 Million61.86% of portfolio
-
Black Rock Inc. New York, NY9.31MShares$63.2 Million0.0% of portfolio
-
Trigran Investments, Inc.7.6MShares$51.6 Million9.43% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.71MShares$45.6 Million0.0% of portfolio
-
Paradigm Capital Management Inc4.68MShares$31.8 Million1.99% of portfolio
About MIMEDX GROUP, INC.
- Ticker MDXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 113,609,000
- Market Cap $771M
- Description
- MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...